Fosfomycin Formulations: Tromethamine vs Other Salts
Yes, oral fosfomycin is formulated as fosfomycin tromethamine (also called fosfomycin trometamol), while intravenous fosfomycin exists as different salt formulations—specifically fosfomycin disodium in the United States and fosfomycin calcium in Europe and Asia. 1, 2
Key Distinctions Between Formulations
Oral Formulation
- Salt form: Fosfomycin tromethamine (trometamol)
- Presentation: White powder in sachets, dissolved in water before administration 1
- Bioavailability: 34-41% oral bioavailability 3
- Peak urinary concentrations: 1053-4415 mg/L within 4 hours, maintained >128 mg/L for 24-48 hours 4
- Standard dosing: Single 3g dose for uncomplicated UTI 4
Intravenous Formulations
- US formulation: Fosfomycin disodium (brand name CONTEPO) 2
- European/Asian formulation: Fosfomycin calcium salt 1
- Critical difference: IV fosfomycin is not available in the United States 1
Clinical Implications of Salt Formulations
The tromethamine salt was specifically developed to overcome the poor oral bioavailability of earlier fosfomycin formulations 5. This salt form achieves:
- Sustained urinary concentrations lasting 24-48 hours after a single dose
- Sufficient tissue penetration in bladder mucosa for at least 36 hours 6
- Prevention of resistant variant emergence through prolonged bactericidal activity 5
Important Sodium Content Warning
The IV disodium formulation delivers 330 mg of sodium per gram of fosfomycin—significantly higher than other IV antibiotics like piperacillin/tazobactam (65 mg sodium per gram) 1. This requires careful monitoring in patients with:
- Heart failure
- Renal impairment
- Fluid/electrolyte disorders
Practical Considerations
When prescribing or discussing fosfomycin, always specify the formulation:
- "Fosfomycin tromethamine" or "fosfomycin trometamol" = oral formulation
- "Fosfomycin disodium" = IV formulation (US only)
- "Fosfomycin calcium" = IV formulation (Europe/Asia)
The terms are often used interchangeably in clinical practice, but the salt form matters for:
- Route of administration
- Sodium load considerations
- Geographic availability
- Pharmacokinetic properties
Bottom line: When someone refers to oral fosfomycin without specifying the salt, they are referring to fosfomycin tromethamine/trometamol, as this is the only oral formulation available and approved for clinical use 1, 3, 4.